Articles
EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate
December 5, 2025
IP Updates
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Never miss an Insight.
Sign upEvent
Paragraph IV Disputes Master Symposium Paragraph IV Disputes Master Symposium
September 19-20, 2016
Chicago
Event
Intellectual Property Throughout the Drug Development Lifecycle: Opportunities and Challenges Intellectual Property Throughout the Drug Development Lifecycle: Opportunities and Challenges
July 17, 2012
Washington
Conference
Outsourcing Drug Discovery: Partnership and Licensing Tactics Outsourcing Drug Discovery: Partnership and Licensing Tactics
May 9-10, 2012
Philadelphia
Articles
Challenges Facing Chinese Companies Exporting to the United States Challenges Facing Chinese Companies Exporting to the United States
January 5, 2012
Imp-Exp Executive MagazineEvent
The 6th Annual Conference on Corporate Intellectual Property in China The 6th Annual Conference on Corporate Intellectual Property in China
May 26-27, 2011
Shanghai
Articles
The Interplay Between U.S. Pharmaceutical Patents and FDA Law The Interplay Between U.S. Pharmaceutical Patents and FDA Law
December 2010
Managing Intellectual Property, Chinese editionArticles
The Importance of Intellectual Property Rights in Business Deals The Importance of Intellectual Property Rights in Business Deals
October 2010
China IP NewsEvent
Advanced Intellectual Property Seminars Advanced Intellectual Property Seminars
July 2, 2010
Shanghai
Event
MIP Inaugural China-International IP Forum MIP Inaugural China-International IP Forum
June 29, 2010
Beijing
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.